Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial
Title:
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial
Author:
Aluwini, Shafak Pos, Floris Schimmel, Erik Krol, Stijn van der Toorn, Peter Paul de Jager, Hanja Alemayehu, Wendimagegn Ghidey Heemsbergen, Wilma Heijmen, Ben Incrocci, Luca